Health · Full coverage
Israeli Firm DreamD Receives FDA Approval for Diabetes App
How 3 Israeli newsrooms covered this story — translated into English and compared side by side.
Center 1Unrated 2
By בן פלמון
What happened
Israeli company DreamD secured FDA approval for its Modi app, which provides personalized insulin dosage recommendations for type 2 diabetes patients using injections. The app analyzes glucose and insulin data to offer guidance between doctor visits.
- 01Israeli company DreamD's Modi app received FDA approval for type 2 diabetes patients.
- 02The app provides personalized insulin dosage recommendations via smartphone.
- 03It analyzes continuous glucose monitoring and insulin treatment data.
- 04Modi is the first FDA-approved solution for insulin injection users.
- 05The app is named after Mordechai 'Modi' Amir, killed on October 7.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Ask About This Story
Duki reads it, and every newsroom on the same story, then answers with sources.
Full coverage · 3 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.